Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Savara Inc
SVRACurrent price
3.07 USD
-0.04 USD (-1.29%)
Last closed
3.11 USD
Company
www.savarapharma.com
ISIN
US8051111016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
537 523 008 USD
Yield for 12 month
-31.47 %
1Y
3Y
5Y
10Y
15Y
SVRA
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Langhorne, Pennsylvania. Address: 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.31 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+272 000 USD
Current Year
–
Last Year
-44 262 000 USD
Current Quarter
–
Last Quarter
+136 000 USD
Key Figures SVRA
1 year
3 years
5 years
10 years
EBITDA
-108 244 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-38.97 %
PEG Ratio
–
Return On Equity TTM
-75.77 %
Wall Street Target Price
9.31 USD
Revenue TTM
1 000 USD
Book Value
0.70 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-77 631 000 USD
Earnings per share
-0.49 USD
Diluted Eps TTM
-0.49 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SVRA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History SVRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:70
Payout Ratio TTM
–
Last Split Date
28.04.2017
Stock Valuation SVRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
11.91
Price Sales TTM
131 146.00
Enterprise Value EBITDA
-4.76
Price Book MRQ
3.64
Financials SVRA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SVRA
For 52 weeks
2.26 USD
5.11 USD
50 Day MA
2.92 USD
Shares Short Prior Month
16 909 699
200 Day MA
3.38 USD
Short Ratio
23.00
Shares Short
17 178 297
Short Percent
11.84 %
BeatStart